A comparative review of recently developed particulate drug carrier systems

Pharmaceutical Reviews

Volumn 7, Issue 3, 2009, Pages

  Gilhotra, Ritu Mehra ^a   Bhardwaj, Vishva Priya ^c   Mishra, D N ^b  

^a SURESH GYAN VIHAR UNIVERSITY   (India)

^b GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

^c NONE

Author keywords

Drug carriers; Micro; Nano particulate systems; Targeted drug delivery

Indexed keywords

DENDRIMER; DRUG CARRIER; LIPID EMULSION; LIPOPLEX; LIPOSOME; NANOCAPSULE; NANOCARRIER; NANOCRYSTAL; NANOSPHERE; NANOTUBE; NANOWIRE; NIOSOME; POLYMER;

CERAMICS; COLLOID; DRUG DELIVERY SYSTEM; DRUG INDUSTRY; HYDROGEL; MICROBUBBLE; MICROTUBULE; PARTICULATE MATTER; POLYMERIZATION; REVIEW;

EID: 77953448626     PISSN: None     EISSN: 19185561     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Roco M. C., Nanotechnology: convergence with modern biology and medicine, Curr. Opin. Biotechnol., 2003,14, 337-343
2. Gupta,R.B. and Kompella, Nanoparticle Technology for Drug Delivery, Taylor & Francis Group, New York, U.B. Eds. 2006 pp. 1-379.
3. Wilkinson J. M., Nanotechnology applications in medicine. Med. Device Technol., (2003), 14, 29-31
4. Roco M. C., Williams R. S., Alivisatos P. (eds.), Biological, medicaland health applications. "Nanotechnology Research Directions,"Chap. 8, Kluwer Academic Publishers, Boston, 2000. URLhttp://nano.gov.
5. Schimidt J., Montemagno C., Using machines in cells Drug Discov. Today, 2002, 7, 500-503
6. Yamamoto H., Kuno Y., Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctionsSugimoto S., Takeuchi H., Kawashima Y., J.,Contr. Rel., 2005,102, 373-381
7. D.A. McCure, in: T. Higuchi, V. Stella (Eds.), Prodrugs asinserts for controlled release of antibiotics, Biomaterials 4 Novel Drug Delivery Systems, American Chemical Society,1983 170-174. Washington, DC , 1975, pp. 224
8. Kreuter J., Nanoparticulate systems for brain delivery of drugs Adv. Drug Del. Rev., 2001,47, 65-81
9. Cohen H., Levy R. J., Gao J., Fishbein I., Kousaev V., Sosnowski S.,Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles Gene Ther., 2000., 7, 1896-1905
10. Lobenberg R., Kreuter J., Macrophage targeting of azidothymidine: a promising strategy for AIDS therapy. AIDS Res. Hum. Retroviruses, 1996, 12, 1709-1715
11. Hoet Peter H. M., Hohlfeld I. B., Salata O. V., J. Nanobiotechnol., 2004,2,1-5
12. Rabinow BE , Nanosuspensions in drug delivery,Nat. Rev. Drug Discov., 2004,3, 785-796
13. Goldstein A. S. M., Amory J. K., Martin S. M., Vemon C., MatrumotomA., Yagerm P., Bioorg. Med. Chem., 2001, 9, 2819-2825 .
14. Bangham A. D., Standish M. M., Watkins J. C., J. Mol. Biol., 1965, 13,238-252
15. Garcia-fuentes M.,Torres D.,Alonso M.J., New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin. Int. J. Pharm., 2005) ,296,122-132.
16. Vyas S. P., Khar R. K., "Targeted and Control Drug Delivery," 1st ed.,Chap. 9, CBS Publishers and Distributors, New Delhi, 2002, pp.331-385
17. Luo D., Han Et., Belcheva N., Saltzman W. M., J. Control. Rel., 2004, 95,333-341.
18. Akiyoshi K., Kobayashi S., Shichibe S., Mix D., Baudys M., Kim S.W., Sunamoto J., Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: complexation and stabilization of insulin., J. Control. Rel., 1998,4, 313-320.. (Pubitemid 28412662)
19. Wang N., Wu X. S., Preparation and characterization of agarose hydrogel nanoparticles for protein and peptide drug delivery.,Pharm. Dev. Technol., 1997,2, 135-142 ..
20. Weng H., Zhou J., Tangm L., Hu Z., Biomater. Sci. Polym., 2004, 15,1167-1180.
21. Hillery A. M., Toth I., Shaw A. J., Florence A. T., Alexander T., J.Control. Rel., 1996, 41, 271-281..
22. Hermanson G. T., "Bioconjugate Techniques," Academic Press, SanDiego, California, 1996.
23. Goldstein A. S. M., Amory J. K., Martin S. M., Vemon C., Matrumotom A., Yagerm P., Bioorg. Med. Chem., 2001, 9, 2819-2825.
24. Mainardes, R.M.; Silva, L.P.. (2004) Current Drug Targets, 5 (5),389-406.
25. ConstantinidsP.P., Scalart J.P., Lancastar S., Marcello J.,Marks G.,Ellen H.,Smith P.L., Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides., Pharm. Res. ,1994,11,1385-1390
26. Meilander N.J.,Yu X., Ziats N.P.,Bellam-Konda R.V., Lipid-based microtubular drug delivery vehicles., 2001,71,141-152.
27. Bekerdjian R.,Chen S., Grayburn P.A., Shohet R.V., Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction. Ultrasound in Med. Biol., 2005,31,687-691
28. Bekerman T. Golenser J., Cyclosporin nanoparticulate lipospheres for oral administration, Domb A.,J. Pharm. Sic., 2004,93,1264-1270.
29. Jain S, Tiwary AK, Sapra B, Jain NK. Formulation and Evaluation of Ethosomes for Transdermal Delivery of Lamivudine. AAPS PharmSciTech. 2007;8(4):Article 111
30. Bhadra D , Gupta G, Bhadra S, Umamaheshwari RB , Jain N .,Multicomposite ultrathin capsules for sustained ocular delivery of ciprofloxacin hydrochloride, J Pharm Pharm Sci. 2004 Jul 16;7(2):241-251 (Pubitemid 41528898)
31. Meilander N.J., Yu X., Ziats N.P., Bellam-Konda R.V., Lipid-based microtubular drug delivery vehicles., 2001,71,141-152
32. Tomalia D. A., Baker H., Dewald J., Hall M., Kallos G., Martin S.,Roeck J., Ryder J., Smith P., Polym. J., 1985, 17, 117-132.
33. Shilpi S , Jain A , Gupta Y , Jain SK . Colloidosomes: an emerging vesicular system in drug delivery, Crit Rev Ther Drug Carrier Syst. 2007;24(4):361-391
34. Carafa, M.; Santucci, E.; Alhaique, F.; Coviello, T.; Murtas, E.;Riccieri, F.M.; Lucania, G.; Torrisi, M.R. Int. J. Pharm., 1998,160 (1), 51-59.
35. Vyas SP , Mysore N, Jaitely V, Venkatesan N., Discoidal niosome based controlled ocular delivery of timolol maleate, Pharmazie., 1998 Jul;53(7):466-469 (Pubitemid 28338283)
36. Blazek-Welsh AI, Rhodes DG. Maltodextrin-Based Proniosomes. AAPS PharmSci. 2001; 3 (1):article 1. DOI: 10.1208/ps030101
37. Kreuter J., Nanoparticulate systems for brain delivery of drugsAdv. Drug Del. Rev., 2001,47, 65-81
38. Kreilgaard, M. Adv. Drug Del. Rev., 2002, 54 (1),77-98.
39. Nishiyama N., Kataoka K., Polymeric micelle drug carrier systems: PEGPAsp( Dox) and second generation of micellar drugs. Adv. Exp. Med. Biol., 2003,519, 155-177 .
40. Savic R., Luo L., Eisenberg A., Maysinger D., Micellar nanocontainers distribute to defined cytoplasmic organelles Science, 2003,300, 615-618.
41. Yen FL, Wu TH, Lin LT, Cham TM , Lin CC Nanoparticles formulation of Cuscuta chinensis prevents acetaminophen-induced hepatotoxicity in rats Pharmazie., 1998 Jul;53(7)
42. Olbrich C., Bakowsky U. , Lehr C. M., Muller R. H., Kneuer C., J.Control. Rel., 2001, 77, 345-355.
43. Ramanathan S., Qiu B., Pooyan S., Zhang G., Stein S., Leibowitz M.J., Sinko P. J., Targeted PEG-based bioconjugates enhance the cellular uptake and transport of a HIV-1 TAT nonapeptide, J. Control. Rel., 77, 2001, 199-212. (Pubitemid 33145472)
44. Schneider B. H., Dickinson E. L., Vach M. D., Hoizer J. V., HowardL. V., Highly sensitive optical chip immunoassays in human serum.,Biosensor Bioelectronics, 2000,15, 13-22.
45. Chingunpitak J , Puttipipatkhachorn S, Chavalitshewinkoon-Petmitr P, Tozuka Y, Moribe K, Yamamoto K Formation, physical stability and in vitro antimalarial activity of dihydroartemisinin nanosuspensions obtained by co-grinding method, Drug Dev Ind Pharm. 2008 Mar;34(3):314-322
46. Khoee S, Yaghoobian M, An investigation into the role of surfactants in controlling particle size of polymeric nanocapsules containing penicillin-G in double emulsion,Eur J Med Chem., 2008, Oct 10.
47. Veerareddy PR, Vobalaboina V, Ali N Antileishmanial activity, pharmacokinetics and tissue distribution studies of mannose-grafted amphotericin B lipid nanospheres,J Drug Target. 2009 Feb;17,
48. Muller R. H., Jacobs C., Kayser O., Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the futureAdv. Drug Del. Rev., 2001, 47, 3-19.
49. Vinognadov S., Batrakova E., Kabanov A., Colloids and Surfaces B.Biointerfaces, 1999 ,16,291-304 .
50. Zhang Y., Calon F., Zhu C., Boado R. J., Pardridge W. M., Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism., Hum.Gene Ther., 2003, 14, 1-12.
51. Shivakumar H.N., Patel P.B., Desai B. G.,Ashok P., Design and statistical optimization of glipizide loaded lipospheres using response surface methodology, Acta Pharm. ,2007, 57 269-285 (Pubitemid 47429176)
52. Mokhtar M., Sammour O.A., Hammad M.A., Megrab N.A., Effect of some formulation parameters of flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. International journal of pharmaceutics, 361(2008) 104-111.
53. Choi Y., Thomas T., Kotlyar A., Islam M. T., Baker J. R.,Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting, Chem.Biol., 2005, 12, 35-43. (Pubitemid 40118324)
54. Harpham MR, Süzer O, Ma CQ, Bäuerle P, Goodson T ,Thiophene Dendrimers as Entangled Photon Sensor MaterialsJ Am Chem Soc. 2009 Jan 5.
55. Torchilin V. P., Lukyanov A. N., Gao Zhonggao., Sternberg P. B., Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs.Proc. Natl. Acad. Sci. U.S.A., 2003,100, 6039-6044.
56. Dua K., Sharma V. K., Yadav V.P.,Shamad A., Nanomedicin:Therapeutic and Diagnostic Prospects, The Pharma Review 2008,89-94.
57. Goyal AK, Khatri K, Mishra N, Mehta A, Vaidya B, Tiwari S, Vyas SP Aquasomes - a nanoparticulate approach for the delivery of antigenDrug Dev Ind Pharm. 2008 Dec;34(12):1297-1305